The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
10X GENOMICS INC-CLASS A | COM | 88025U109 | 5,322 | 37,587 | SH | SOLE | 37,587 | 0 | 0 | ||
ARCUS BIOSCIENCES INC | COM | 03969F109 | 9,045 | 348,408 | SH | SOLE | 348,408 | 0 | 0 | ||
ARENA PHARMACEUTICALS INC | COM | 040047607 | 7,779 | 101,245 | SH | SOLE | 101,245 | 0 | 0 | ||
AVADEL PHARMACEUTICALS PLC | ADR | 05337M104 | 6,385 | 955,856 | SH | SOLE | 955,856 | 0 | 0 | ||
BCLS ACQUISITION CORP- CL A | COM | G0904B105 | 993 | 89,135 | SH | SOLE | 89,135 | 0 | 0 | ||
BIODESIX INC | COM | 09075X108 | 9,656 | 478,985 | SH | SOLE | 478,985 | 0 | 0 | ||
BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 7,734 | 88,195 | SH | SOLE | 88,195 | 0 | 0 | ||
BRISTOL-MYERS SQUIBB-CVR | RTS | 110122157 | 3,555 | 5,152,098 | SH | SOLE | 5,152,098 | 0 | 0 | ||
BURNING ROCK BIOTECH LTD-ADR | ADR | 12233L107 | 5,030 | 217,728 | SH | SOLE | 217,728 | 0 | 0 | ||
C4 THERAPEUTICS INC | COM | 12529R107 | 4,616 | 139,343 | SH | SOLE | 139,343 | 0 | 0 | ||
CODEXIS INC | COM | 192005106 | 6,953 | 318,492 | SH | SOLE | 318,492 | 0 | 0 | ||
FATE THERAPEUTICS INC | COM | 31189P102 | 4,611 | 50,709 | SH | SOLE | 50,709 | 0 | 0 | ||
FLUIDIGM CORP | COM | 34385P108 | 9,269 | 1,544,904 | SH | SOLE | 1,544,904 | 0 | 0 | ||
FORTE BIOSCIENCES INC | COM | 34962G109 | 3,094 | 84,989 | SH | SOLE | 84,989 | 0 | 0 | ||
GALECTO INC | COM | 36322Q107 | 4,220 | 337,352 | SH | SOLE | 337,352 | 0 | 0 | ||
GUARDANT HEALTH INC | COM | 40131M109 | 10,212 | 79,239 | SH | SOLE | 79,239 | 0 | 0 | ||
INSULET CORP | COM | 45784P101 | 11,663 | 45,624 | SH | SOLE | 45,624 | 0 | 0 | ||
INTRA-CELLULAR THERAPIES INC | COM | 46116X101 | 4,155 | 130,654 | SH | SOLE | 130,654 | 0 | 0 | ||
ITEOS THERAPEUTICS INC | COM | 46565G104 | 4,680 | 138,384 | SH | SOLE | 138,384 | 0 | 0 | ||
JAZZ PHARMACEUTICALS PLC | COM | G50871105 | 14,836 | 89,889 | SH | SOLE | 89,889 | 0 | 0 | ||
KALVISTA PHARMACEUTICALS INC. | COM | 483497103 | 891 | 46,910 | SH | SOLE | 46,910 | 0 | 0 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 11,317 | 346,518 | SH | SOLE | 346,518 | 0 | 0 | ||
MEREO BIOPHARMA GROUP PL-ADR | COM | 589492107 | 2,649 | 739,812 | SH | SOLE | 739,812 | 0 | 0 | ||
NANOSTRING TECHNOLOGIES INC | COM | 63009R109 | 11,561 | 172,862 | SH | SOLE | 172,862 | 0 | 0 | ||
NOVUS THERAPEUTICS INC | COM | 67011N105 | 1,233 | 80,069 | SH | SOLE | 80,069 | 0 | 0 | ||
NUCANA PLC-ADR | ADR | 67022C106 | 2,756 | 613,769 | SH | SOLE | 613,769 | 0 | 0 | ||
ORIC PHARMACEUTICALS INC | COM | 68622P109 | 2,275 | 67,210 | SH | SOLE | 67,210 | 0 | 0 | ||
PMV PHARMACEUTICALS INC | COM | 69353Y103 | 5,942 | 96,595 | SH | SOLE | 96,595 | 0 | 0 | ||
SAGE THERAPEUTICS INC | COM | 78667J108 | 15,715 | 181,650 | SH | SOLE | 181,650 | 0 | 0 | ||
SUTRO BIOPHARMA INC | COM | 869367102 | 3,421 | 157,583 | SH | SOLE | 157,583 | 0 | 0 | ||
Viatris Inc | COM | 92556V106 | 21,186 | 1,130,504 | SH | SOLE | 1,130,504 | 0 | 0 | ||
VISTAGEN THERAPEUTICS INC | COM | 92840H202 | 4,345 | 2,239,803 | SH | SOLE | 2,239,803 | 0 | 0 | ||
WAVE LIFE SCIENCES PTE LTD | COM | Y95308105 | 2,211 | 280,924 | SH | SOLE | 280,924 | 0 | 0 |